This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Agenus" – news · newspapers · books · scholar · JSTOR(July 2022) (Learn how and when to remove this message)
Agenus Inc.
Company type
Public
Traded as
Nasdaq: AGEN Russell 2000 Component
Industry
Biotechnology
Pharmaceutical Company
Founded
1994; 30 years ago (1994)
Founders
Garo H. Armen, Pramod K. Srivastava
Headquarters
3 Forbes Road, Lexington, Massachusetts, USA
Key people
Garo H. Armen
(chairman and CEO)
Jennifer Buell
(president and COO)
Website
www.agenusbio.com
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants desugned for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.[1]
partners are sponsoring approximately 20 clinical trials of Agenus products. Merck: April 2014, Agenus announced a deal worth potentially $100 million with Merck...
epithet album by Anton and attributed with uncertainty to Agenus, it could be denoted "Agenus? album Anton (?Anton)"; the "(?Anton)" indicates the author...
Narayen Chairman, president and CEO 2007 Formerly with Apple 2018-10-01 Agenus Garo H. Armen Founder, chairman, CEO 1994 Founder of the Children of Armenia...
developed by the American biopharmaceutical company Antigenics Inc. (now Agenus) that is evaluated in multiple clinical trials. It has been granted fast...
HerpV, a genital herpes vaccine candidate manufactured by the company Agenus, announced Phase II clinical trial results in June 2014. Results showed...
Global Information